GovChime

CDER-2023-118707-Delivery of Human Blood Donor for Bioassay Development.

Overview

Response deadline
12:00 PM UTC−04:00
Posted
June 7, 2023
Notice type
Combined Synopsis/Solicitation
Set-aside
Total Small Business Set-Aside (FAR 19.5)
Agency
Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION

Notice details

Office
FDA OFFICE OF ACQ GRANT SVCS
Place of performance
Silver Spring, MD, 20903
Last updated
Dec 4, 2025

Identifiers

Solicitation number
FDA-RFQ-CDER-2023-118707
Notice ID
fbad75b07fa14203b53043094c0f9ab1

Description

The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement to procure CDER-2023-118707 Delivery of Human Blood Donor for Bioassay Development. Per Attached RFQ

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:FDA-RFQ-CDER-2023-118707
  1. Combined Synopsis
  1. 2×
    Combined SynopsisCurrentJun 7, 2023

    CDER-2023-118707-Delivery of Human Blood Donor for Bioassay Development.

    Notice fbad75b07fa14203b53043094c0f9ab1 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

FDA-RFQ-CDER-2023-118707

Archive Date

Jul 10, 2023

Office Address

Beltsville, MD, 20705